Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DEXAMETHASONE | 4MG | TABLET | Resolved | 2025-09-11 | 2025-10-03 | 267029 |
| APO-DEXAMETHASONE | 0.5MG | TABLET | Resolved | 2017-10-03 | 2017-11-28 | 24257 |
| APO-DEXAMETHASONE | 4MG | TABLET | Resolved | 2025-01-09 | 2025-01-31 | 247382 |
| APO-DEXLANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-06-14 | 2024-12-06 | 230576 |
| APO-DEXLANSOPRAZOLE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-06-14 | 2024-12-06 | 230579 |
| APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2022-01-07 | 2022-02-18 | 152304 |
| APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2023-01-26 | 2023-04-21 | 182361 |
| APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2024-07-04 | 2024-07-19 | 232306 |
| APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2020-08-06 | 2020-09-28 | 121894 |
| APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2019-10-09 | 2019-12-09 | 95861 |
| APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2023-12-22 | 2024-02-23 | 214238 |
| APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2023-08-12 | 2023-10-06 | 201704 |
| APO-DICLO RAPIDE 50 MG TABLETS | 50MG | TABLET | Resolved | 2017-10-11 | 2017-11-22 | 25207 |
| APO-DICLO RAPIDE 50 MG TABLETS | 50MG | TABLET | Actual shortage | 2019-11-13 | 2019-11-13 | 98557 |
| APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) | Resolved | 2024-10-31 | 2024-11-22 | 241685 |
| APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-01 | 2024-01-05 | 212392 |
| APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) | Resolved | 2021-11-22 | 2021-12-20 | 149705 |
| APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-07-11 | 2020-01-07 | 55267 |
| APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) | Resolved | 2024-07-04 | 2024-08-16 | 232303 |
| APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-08-01 | 2024-08-16 | 234274 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |